-
Loading metrics
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes
- Judit Hodrea,
- Adar Saeed,
- Agnes Molnar,
- Attila Fintha,
- Adrienn Barczi,
- Laszlo J. Wagner,
- Attila J. Szabo,
- Andrea Fekete,
- Dora B. Balogh
x
- Published: February 17, 2022
- https://doi.org/10.1371/journal.pone.0263285